The Italian NBIA patient advocacy Associazione Italiana Sindromi Neurodegenerative da Accumulo di Ferro (AISNAF) is currently accepting applications for research grants that will pave the way to new potential treatments for NBIA diseases. Funds were made available through contributions from AISNAF, Hoffnungsbaum e.V. (HoBa, Germany) and NBIA Disorders Association (NBIADA, USA). While AISNAF is the grant manager, all three funding organizations have equal responsibilities and rights, which includes nominating representatives to participate on the Scientific Advisory Board and Lay Review Board for each grant call.
Specifically, this is a two-track granting cycle that solicits proposals on the following diseases belonging to the NBIA current classification:
1) Beta-Propeller-Protein Associated Neurodegeneration (BPAN – Gene WDR45):
Funds are available to support an 18-month research project on BPAN for up to € 65,000
2) Mitochondrial Membrane-Protein (MPAN – Gene c19orf12):
Funds are available to support a two-year research project on MPAN for up to € 90,000
Deadline for proposal submission: May 13, 2019
Applicants are kindly invited to visit https://www.aisnaf.org/bandi-per-progetti-calls-for-proposals/ for detailed information on the grant call and application guidelines.